1. Home
  2. WF vs VTRS Comparison

WF vs VTRS Comparison

Compare WF & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Woori Financial Group Inc. (each representing three (3) shares of)

WF

Woori Financial Group Inc. (each representing three (3) shares of)

HOLD

Current Price

$61.53

Market Cap

14.6B

Sector

Finance

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$13.23

Market Cap

14.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WF
VTRS
Founded
1899
1961
Country
South Korea
United States
Employees
N/A
N/A
Industry
Commercial Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6B
14.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WF
VTRS
Price
$61.53
$13.23
Analyst Decision
Hold
Analyst Count
0
6
Target Price
N/A
$11.50
AVG Volume (30 Days)
51.5K
8.0M
Earning Date
03-04-2026
02-26-2026
Dividend Yield
3.48%
3.63%
EPS Growth
20.51
N/A
EPS
2.97
N/A
Revenue
$8,054,512,650.00
$14,124,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.37
$1.18
P/E Ratio
$6.75
N/A
Revenue Growth
23.56
N/A
52 Week Low
$29.44
$6.85
52 Week High
$61.82
$13.49

Technical Indicators

Market Signals
Indicator
WF
VTRS
Relative Strength Index (RSI) 66.70 66.94
Support Level $56.60 $12.55
Resistance Level $58.39 $13.31
Average True Range (ATR) 1.47 0.34
MACD 0.24 -0.01
Stochastic Oscillator 92.06 79.23

Price Performance

Historical Comparison
WF
VTRS

About WF Woori Financial Group Inc. (each representing three (3) shares of)

Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. The operating segments of the company include Banking, Credit card, Capital, Investment banking, and others.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: